v3.24.1.u1

Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash	$ 16,234	$ 163
Total Current Assets	16,234	163
Total Assets	16,234	163
Current Liabilities
Accounts payable	6,000	6,000
Notes payable	286,021	255,021
Accrued interest	171,414	150,477
Total Current Liabilities	463,435	411,498
Total Liabilities	463,435	411,498
Stockholders' Deficit
Preferred stock, $.001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $.001 par value; 50,000,000 shares authorized; 708,000 shares issued and outstanding	708	708
Additional paid in capital	25,148	25,148
Accumulated deficit	(473,057)	(437,191)
Total Stockholders' Deficit	(447,201)	(411,335)
Total Liabilities and Stockholders' Deficit	$ 16,234	$ 163

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

SKINOVATION PHARMACEUTICAL INC 10-K